Page last updated: 2024-08-22

zalcitabine and Neuroblastoma

zalcitabine has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD1
Cook, HW; Spence, MW1

Other Studies

2 other study(ies) available for zalcitabine and Neuroblastoma

ArticleYear
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
    Experimental neurology, 2015, Volume: 267

    Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine

2015
Dideoxycytidine, an anti-HIV drug, selectively inhibits growth but not phosphatidylcholine metabolism in neuroblastoma and glioma cells.
    Neurochemical research, 1989, Volume: 14, Issue:3

    Topics: Cell Division; Dideoxynucleosides; Glioma; Humans; Neuroblastoma; Phosphatidylcholines; Tumor Cells, Cultured; Zalcitabine

1989